Rockwell Medical Stock Price - RMTI

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 2.42 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Rockwell Medical Inc RMTI NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.12 -4.72% 2.42 2.5955 2.39 2.55 2.54 18:00:58
Bid Price Ask Price Spread Spread % News
2.23 4.10 1.87 45.61% 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,465 134,481 $ 2.48 $ 332,979 249,651 2.19 - 6.88
Last Trade Time Type Quantity Stock Price Currency
16:00:11 formt 172 $ 2.42 USD

Rockwell Medical Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 154.46M 63.82M $ -32.13M -0.62 -4.06 57.08M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 29.00 10.60%

more financials information »

Rockwell Medical News

Loading Messages....

Latest RMTI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RMTI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.402.59552.342.44171,6970.020.83%
1 Month3.433.462.342.58218,616-1.01-29.45%
3 Months3.083.462.252.63290,522-0.66-21.43%
6 Months4.605.80222.253.26343,397-2.18-47.39%
1 Year4.246.882.193.68315,438-1.82-42.92%
3 Years6.158.982.195.15272,944-3.73-60.65%
5 Years10.1118.89992.198.18401,578-7.69-76.06%

Rockwell Medical Description

Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The company's drug products are Triferic and Calcitriol. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. It replaces the ongoing iron loss that occurs to patients during every hemodialysis treatment, via dialysate. Calcitriol is a generic drug for treating secondary hyperparathyroidism in dialysis patients. The company operates in one segment of hemodialysis market which involves the manufacture, sale, and distribution of hemodialysis products.

Your Recent History
Rockwell M..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.